Susquehanna International Group, LLP Novo Cure LTD Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Novo Cure LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 239,591 shares of NVCR stock, worth $4.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,591
Previous 75,615
216.86%
Holding current value
$4.07 Million
Previous $2.25 Million
89.48%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$191 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$152 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$93.9 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$88.7 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.78B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...